Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health monitoring news

Show

From To
Marathon training is safe for people with HIV

Marathon run training is safe for people with HIV, investigators from Germany report in BMC Infectious Diseases. Training also had a number of beneficial effects,

Published
21 September 2017
By
Michael Carter
Single measures of viral load not effective for assessing HIV suppression status

The percentage of HIV-positive individuals with durable viral suppression may be overestimated when calculated by single measures of viral load, according to findings published in Annals of Internal Medicine.

Published
08 August 2017
From
Healio
Viral Rebound Unlikely for Many on ART

British investigators have determined that a substantial proportion of people with HIV who are taking antiretroviral therapy (ART) will not experience viral rebound during their lifetime.

Published
14 July 2017
From
Infectious Disease Special Edition
Do People With HIV Need Annual Physical Examinations?

Are yearly comprehensive physical exams a waste of time in people with HIV, or do higher rates of cancer and other clinical conditions merit more intense screening? Clinical practice guidelines don't put this to rest.

Published
12 July 2017
From
The Body PRO
Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk, investigators from the

Published
05 July 2017
By
Michael Carter
HIV drug resistance testing not a priority for resource-limited settings, trial finds

Resistance testing is unlikely to improve the effectiveness of second-line HIV treatment in resource-limited settings and the introduction of routine HIV drug resistance testing is

Published
14 June 2017
By
Keith Alcorn
Point-of-care CD4 counts improve linkage to HIV care in Kenya

Carrying out a point-of-care CD4 count immediately after a person was diagnosed with HIV by home-based testing doubled the rate of linkage to HIV care,

Published
06 June 2017
By
Keith Alcorn
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in The Lancet HIV journal and reported widely in the news, has found substantial

Published
15 May 2017
By
Gus Cairns
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

Protease inhibitors may not be the best class of drug for people newly diagnosed with HIV to start treatment with, if they wish to quickly

Published
12 May 2017
By
Gus Cairns
New Study Reveals why people with HIV are more likely to develop Emphysema

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop the chronic lung disease emphysema in their lifetime. Now, new research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Published
10 May 2017
From
Weill Cornell Medicine
← First12345...58Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.